Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Notes Payables (2021 - 2025)

Celularity has reported Notes Payables over the past 5 years, most recently at $4.3 million for Q3 2025.

  • Quarterly results put Notes Payables at $4.3 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $4.3 million (changed N/A YoY), and the annual figure for FY2024 was $3.9 million, down 77.5%.
  • Notes Payables for Q3 2025 was $4.3 million at Celularity, roughly flat from $4.3 million in the prior quarter.
  • Over the last five years, Notes Payables for CELU hit a ceiling of $39.3 million in Q3 2022 and a floor of $120000.0 in Q1 2021.
  • Median Notes Payables over the past 5 years was $9.2 million (2023), compared with a mean of $14.5 million.
  • Biggest five-year swings in Notes Payables: plummeted 54.2% in 2023 and later plummeted 77.5% in 2024.
  • Celularity's Notes Payables stood at $1.1 million in 2021, then skyrocketed by 3289.89% to $37.6 million in 2022, then plummeted by 54.2% to $17.2 million in 2023, then plummeted by 77.5% to $3.9 million in 2024, then grew by 10.53% to $4.3 million in 2025.
  • The last three reported values for Notes Payables were $4.3 million (Q3 2025), $4.3 million (Q2 2025), and $4.2 million (Q1 2025) per Business Quant data.